Evidence map›Paper›PMID 30271932›Full record

ArticleCommunications biology2018

A truncating mutation in EPOR leads to hypo-responsiveness to erythropoietin with normal haemoglobin.

Gudjon R Oskarsson, Ragnar P Kristjansson, Amy L Lee, Gardar Sveinbjornsson, Magnus K Magnusson, Erna V Ivarsdottir, Stefania Benonisdottir, Asmundur Oddsson, Olafur B Davidsson, Jona Saemundsdottir and 13 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 2 institutions in 1 country.

Gudjon R OskarssondeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Ragnar P KristjanssondeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland. ragnar.kristjansson@decode.is.
Amy L LeedeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Gardar SveinbjornssondeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Magnus K MagnussondeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Erna V IvarsdottirdeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-2069-0681
Stefania BenonisdottirdeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Asmundur OddssondeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-4606-5163
Olafur B DavidssondeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Jona SaemundsdottirdeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Gisli H HalldorssondeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-7067-9862
Joseph ArthurdeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Gudny A ArnadottirdeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-6571-423X
Gisli MassondeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Brynjar O JenssondeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Hilma HolmdeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Isleifur OlafssonDepartment of Clinical Biochemistry, Landspítali University Hospital, 101, Reykjavik, Iceland.
Pall T OnundarsonDepartment of Laboratory Hematology, Landspítali University Hospital, 101, Reykjavik, Iceland.
Daniel F GudbjartssondeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-5222-9857
Gudmundur L NorddahldeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Unnur ThorsteinsdottirdeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.
Patrick SulemdeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-7123-6123
Kari StefanssondeCODE genetics/Amgen, Inc, 101, Reykjavik, Iceland. kstefans@decode.is.
deCODE Genetics (Iceland) · ISReykjavík University · IS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cytokine erythropoietin (EPO), signalling through the EPO receptor (EPO-R), is essential for the formation of red blood cells. We performed a genome-wide association study (GWAS) testing 32.5 million sequence variants for association with serum EPO levels in a set of 4187 individuals. We detect an association between a rare and well imputed stop-gained variant rs370865377[A] (p.Gln82Ter) in

Identifiers

PMID30271932
PMCPMC6123817
OpenAlexW2805549814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.